The Trump administration will not finalize a Biden-era plan to require coverage of anti-obesity medications in Medicare and ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...

Doctors say it’s not uncommon for patients to not lose weight on the GLP-1 drugs, even if celebrities are seemingly shedding dozens of pounds. Julia Musto spoke to people frustrated that they are part ...

Some states that cover the cost of drugs like Wegovy, Ozempic and Zepbound are scrambling to lessen the budgetary squeeze ...

Under the Biden administration proposal unveiled last November, an estimated 3.4 million Americans on Medicare would be eligible in 2026 for the drugs, which carry a list price of more than $1,000 a ...

The buy now, pay later model has taken off. Experts say BNPL can be useful when used responsibly, but shoppers should be careful not to overspend.

This week has been a brutal reminder of how politics and politicians like to work and be seen. How important it is to be the ...

A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications.

A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...